No connection

Search Results

DK vs INVX

DK
Delek US Holdings, Inc.
BEARISH
Price
$39.66
Market Cap
$2.37B
Sector
Energy
AI Confidence
85%
INVX
Innovex International, Inc.
BEARISH
Price
$28.15
Market Cap
$1.93B
Sector
Energy
AI Confidence
85%

Valuation

P/E Ratio
DK
--
INVX
23.46
Forward P/E
DK
28.04
INVX
16.19
P/B Ratio
DK
8.28
INVX
1.84
P/S Ratio
DK
0.22
INVX
1.97
EV/EBITDA
DK
7.18
INVX
10.41

Profitability

Gross Margin
DK
9.2%
INVX
31.0%
Operating Margin
DK
7.07%
INVX
11.56%
Profit Margin
DK
-0.21%
INVX
8.52%
ROE
DK
8.25%
INVX
8.26%
ROA
DK
3.48%
INVX
5.77%

Growth

Revenue Growth
DK
2.3%
INVX
9.1%
Earnings Growth
DK
--
INVX
-56.8%

Financial Health

Debt/Equity
DK
6.49
INVX
0.07
Current Ratio
DK
0.82
INVX
4.91
Quick Ratio
DK
0.51
INVX
3.17

Dividends

Dividend Yield
DK
2.57%
INVX
--
Payout Ratio
DK
308.33%
INVX
0.0%

AI Verdict

DK BEARISH

Delek US Holdings exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health. The company is dangerously over-leveraged with a Debt/Equity ratio of 6.49, far exceeding the sector average of 1.46, and faces liquidity risks with a Current Ratio of 0.82. Furthermore, the dividend is unsustainable with a payout ratio of 308.33%, suggesting it is funded by debt or cash reserves rather than earnings. Despite a bullish analyst consensus and a low PEG ratio, the combination of insider selling and deteriorating deterministic scores suggests a high-risk profile.

Strengths
Very low Price-to-Sales ratio (0.22)
Low PEG ratio (0.38) suggesting potential undervaluation relative to growth
Strong 1-year price appreciation (+217.7%)
Risks
Extreme leverage with Debt/Equity at 6.49
Critical financial health (Piotroski F-Score 2/9)
Unsustainable dividend payout ratio (308.33%)
INVX BEARISH

INVX exhibits strong balance sheet health with a Piotroski F-Score of 7/9 and an exceptionally low debt-to-equity ratio of 0.07. However, the stock is fundamentally overvalued, trading at $28.15 despite a Graham Number of $20.33 and a growth-based intrinsic value of $8.40. This valuation disconnect is exacerbated by a severe collapse in year-over-year earnings growth (-56.8%) and aggressive insider selling totaling over $326 million. While the 1-year price performance is strong, the combination of bearish technicals and massive insider exits suggests the stock is currently priced for perfection in a deteriorating earnings environment.

Strengths
Strong financial health (Piotroski F-Score 7/9)
Extremely low leverage (Debt/Equity 0.07)
High liquidity (Current Ratio 4.91)
Risks
Severe YoY earnings collapse (-56.80%)
Massive insider liquidation ($326.95M in sales)
Significant premium to intrinsic value ($8.40) and Graham Number ($20.33)

Compare Another Pair

DK vs INVX: Head-to-Head Comparison

This page compares Delek US Holdings, Inc. (DK) and Innovex International, Inc. (INVX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI Chat
Markets
Profile